$530 $477 10% OFF Billed every 3 months Full refund if a licensed clinician determines this isn't right for you Microdosed GLP-1 / GIP Clinician-guided, low-dose, two pathways
These additions do not change the sublingual administration technique but may slightly alter the taste of the drops
News provided by Eli Lilly and Company May 21, 2026, 06:45 ET In TRIUMPH-1, participants on 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks with 45.3% of participants achieving 30% weight loss, a level long associated with bariatric surgery Individuals with a baseline BMI 35 who participated in a study extension continued to lose weight, and achieved up to an average of 85.0 lbs (30.3%) weight loss at 104 weeks At the 4 mg dose, reached with only a single escalation step, participants lost an average of 47.2 lbs (19.0%) at 80 weeks with a lower observed discontinuation rate due to adverse events vs
10.2337/db17-1385 [DOI] [PMC free article] [PubMed] [Google Scholar] Alexander, S
Heres what we know so far